NGM395 / NGM Biopharma - LARVOL DELTA

Study of NGM395 in Adult Participants (clinicaltrials.gov) - P1; N=38; Completed; Sponsor: NGM Biopharmaceuticals, Inc; Recruiting ➔ Completed; N=80 ➔ 38; Trial completion date: Dec 2022 ➔ Apr 2021; Trial primary completion date: Dec 2022 ➔ Oct 2020

Clinical • Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Genetic Disorders • Hepatology • Non-alcoholic Fatty Liver Disease • Obesity • MRI

Study of NGM395 in Adult Participants (clinicaltrials.gov) - P1; N=80; Recruiting; Sponsor: NGM Biopharmaceuticals, Inc; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open